Clinical Trial Update: Safety, Tolerability and Pharmacokinetic Investigation of GSK3882347 in Healthy Participants. [Phase 1]

View source ↗

Summary

A Phase 1 safety, tolerability, and pharmacokinetic study of GSK3882347 in healthy participants has been completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Urinary Tract Infection

Drugs mentioned

• GSK3882347

Snippet

Sponsor: GlaxoSmithKline | Conditions: Urinary Tract Infections | Phase 1 | Status: COMPLETED | Results posted: 2023-02-17